Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$19.58 – $25.00
0% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.50B | $1.61B | $2.03B | $1.85B | $1.63B | $1.62B | $2.00B |
| Cost of revenue | $907.1M | $915.0M | $981.0M | $1.22B | $1.23B | $1.03B | $994.5M | $1.18B |
| Gross profit | $582.7M | $584.0M | $632.7M | $807.2M | $625.2M | $616.7M | $624.8M | $825.0M |
| Gross margin | 39.1% | 39.0% | 39.2% | 39.8% | 33.8% | 37.7% | 38.6% | 41.2% |
| R&D | $27.0M | $12.2M | $14.7M | $14.6M | $16.6M | $17.7M | $0 | $20.9M |
| Operating income | $166.1M | $190.6M | $221.1M | $329.9M | $236.6M | $197.4M | $198.5M | $109.1M |
| EBITDA | $226.4M | $199.5M | $261.3M | $408.4M | $288.7M | $275.2M | $272.4M | $260.2M |
| Net income | $484.3M | $111.7M | $160.8M | $246.7M | $158.7M | $148.3M | $76.5M | $101.6M |
| Net margin | 32.5% | 7.5% | 10.0% | 12.2% | 8.6% | 9.1% | 4.7% | 5.1% |
| EPS (diluted) | 0.95 | 0.80 | 1.18 | 1.90 | 1.24 | 1.17 | 0.59 | 0.71 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.1B | $1.45 | $1.38–$1.65 | 8 |
| 2027 | $2.2B | $1.50 | $1.46–$1.55 | 5 |
| 2028 | $2.2B | $1.66 | $1.61–$1.71 | 6 |
| 2029 | $2.3B | $1.77 | $1.72–$1.83 | 5 |
Forward consensus · source: Financial Modeling Prep
ANSELL LTD ORD SHS
No one on the platform currently holds ANSLF.
No tracked institution reports a position in ANSLF as of their last filing.
No one on the platform has traded ANSLF yet.
| $3.8B |
| — |
| SDGCFSundrug Co.,Ltd. | $28.18 | +0.00% | $3.3B | — |
| SHWGFShandong Weigao Group Medical Polymer Company Limited | $0.43 | +0.00% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 10.1× earnings vs its 22.8× historical median P/E.
Fair value ≈ $44.02 · price $19.58 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.